It is important to emphasize that due to the distinct physiological characteristics of biologics, such as stability, specificity, selectivity, and capacity to inhibit particular protein-protein interactions, the biologics sector is expected to expand at a comparatively higher CAGR
That requires: Investigators with metabolic expertise Sub-Investigators capable of leading new teams Coordinators with hands-on clinical skillssuch as phlebotomyand the ability to navigate emerging trial technologies to keep pace with industry demand Staff who can educate patients on complex dosing, titration patterns, and long-term adherence expectations Recruiting for these roles is not a quick fill
View Abstract [7] Lomaestro BM and Malone M
(Lausanne) 13 , 921353 (2022)
But Williams ad isnt by a pharma
Injection Technique General subcutaneous guidance from clinical bestpractice resources [6]